Clearfield (CLFD) Financials

$32.91 +1.67 (+5.35%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$32.91 +0.00 (+0.01%)

As of 08/22/2025 05:52 PM Eastern

Annual Income Statements for Clearfield

This table shows Clearfield's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	9/30/2022	9/30/2023	9/30/2024
Net Income / (Loss) Attributable to Common Shareholders	49	33	-12
Consolidated Net Income / (Loss)	49	33	-12
Net Income / (Loss) Continuing Operations	49	33	-12
Total Pre-Tax Income	64	42	-16
Total Operating Income	64	37	-23
Total Gross Profit	113	85	29
Total Revenue	271	269	167
Operating Revenue	271	269	167
Total Cost of Revenue	158	183	138
Operating Cost of Revenue	158	183	138
Total Operating Expenses	49	48	52
Selling, General & Admin Expense	49	48	52
Total Other Income / (Expense), net	0.02	4.33	6.97
Interest & Investment Income	0.02	4.33	6.97
Income Tax Expense	14	9.08	-3.80
Basic Earnings per Share	$3.58	$2.17	($0.85)
Weighted Average Basic Shares Outstanding	13.77M	14.98M	14.58M
Diluted Earnings per Share	$3.55	$2.17	($0.85)
Weighted Average Diluted Shares Outstanding	13.91M	15.01M	14.58M
Weighted Average Basic & Diluted Shares Outstanding	13.82M	15.25M	14.29M

This table shows Clearfield's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-17	46	14	10	5.22	2.70	-5.27	-5.91	-0.45	-0.83	-1.91
Consolidated Net Income / (Loss)	13	17	14	10	5.22	2.70	-5.27	-5.91	-0.45	-0.83	-1.91
Net Income / (Loss) Continuing Operations	-17	46	14	10	5.22	2.70	-5.27	-5.91	-0.45	-0.83	-1.91
Total Pre-Tax Income	17	22	18	13	7.06	3.26	-6.22	-7.99	-0.72	-1.32	-2.33
Total Operating Income	17	22	18	12	5.63	1.72	-8.16	-9.74	-2.31	-3.01	-3.98
Total Gross Profit	29	38	31	24	19	12	4.70	2.83	11	11	8.18
Total Revenue	0.00	166	86	72	61	50	34	37	49	47	35
Operating Revenue	-	-	86	72	61	50	34	37	49	47	35
Total Cost of Revenue	0.00	99	55	48	42	38	30	34	38	36	27
Operating Cost of Revenue	-	-	55	48	42	38	30	34	38	36	27
Total Operating Expenses	13	15	13	12	13	10	13	13	13	14	12
Selling, General & Admin Expense	13	15	13	12	13	10	13	13	13	14	12
Total Other Income / (Expense), net	0.04	-0.27	0.06	1.28	1.44	1.55	1.94	1.75	1.58	1.69	1.64
Interest & Investment Income	0.04	-0.27	0.06	1.28	1.44	1.55	1.94	1.75	1.58	1.69	1.64
Income Tax Expense	3.88	4.99	3.70	2.97	1.84	0.57	-0.95	-2.08	-0.28	-0.49	-0.43
Basic Earnings per Share	$0.93	$1.22	$1.01	$0.67	$0.33	$0.16	($0.35)	($0.40)	($0.04)	($0.06)	($0.13)
Weighted Average Basic Shares Outstanding	13.77M	13.77M	14.17M	15.23M	15.25M	14.98M	15.21M	14.63M	14.25M	14.58M	14.21M
Diluted Earnings per Share	$0.92	$1.22	$1.00	$0.67	$0.33	$0.17	($0.35)	($0.40)	($0.04)	($0.06)	($0.13)
Weighted Average Diluted Shares Outstanding	13.90M	13.91M	14.28M	15.26M	15.25M	15.01M	15.21M	14.63M	14.25M	14.58M	14.21M
Weighted Average Basic & Diluted Shares Outstanding	13.78M	13.82M	15.25M	-	15.26M	15.25M	14.71M	14.23M	14.24M	14.29M	14.13M

This table details how cash moves in and out of Clearfield's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	9/30/2022	9/30/2023	9/30/2024
Net Change in Cash & Equivalents	3.43	21	-22
Net Cash From Operating Activities	2.26	18	22
Net Cash From Continuing Operating Activities	2.26	18	22
Net Income / (Loss) Continuing Operations	49	33	-12
Consolidated Net Income / (Loss)	49	33	-12
Depreciation Expense	3.43	6.05	7.41
Amortization Expense	-0.04	-3.51	-4.41
Non-Cash Adjustments To Reconcile Net Income	2.34	3.58	4.64
Changes in Operating Assets and Liabilities, net	-53	-20	27
Net Cash From Investing Activities	-8.20	-112	-6.90
Net Cash From Continuing Investing Activities	-8.20	-112	-6.90
Purchase of Property, Plant & Equipment	-9.15	-8.38	-9.57
Acquisitions	-16	0.00	0.00
Purchase of Investments	-0.25	-211	-159
Sale and/or Maturity of Investments	17	107	162
Net Cash From Financing Activities	9.40	115	-37
Net Cash From Continuing Financing Activities	9.40	115	-37
Repayment of Debt	0.00	0.00	-2.17
Repurchase of Common Equity	0.00	0.00	-33
Issuance of Debt	17	-17	2.17
Issuance of Common Equity	0.54	132	0.59
Other Financing Activities, net	-7.85	-0.13	-4.12
Other Net Changes in Cash	-0.02	-0.00	-0.08
Cash Interest Paid	0.12	0.46	0.39
Cash Income Taxes Paid	14	13	0.16

This table details how cash moves in and out of Clearfield's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	0.27	2.46	14	107	-106	6.44	-3.34	-19	9.81	-9.46	14
Net Cash From Operating Activities	1.99	12	1.10	9.04	3.34	4.94	11	-3.23	3.87	14	7.15
Net Cash From Continuing Operating Activities	1.99	12	1.10	9.04	3.34	4.94	11	-3.23	3.87	14	7.15
Net Income / (Loss) Continuing Operations	13	17	14	10	5.22	2.70	-5.27	-5.91	-0.45	-0.83	-1.91
Consolidated Net Income / (Loss)	13	17	14	10	5.22	2.70	-5.27	-5.91	-0.45	-0.83	-1.91
Depreciation Expense	0.84	1.22	1.35	1.47	1.59	1.64	1.65	1.88	1.91	1.93	1.84
Amortization Expense	-0.01	-0.01	-0.22	-0.92	-1.29	-1.08	-1.16	-1.04	-1.11	-1.10	-0.77
Non-Cash Adjustments To Reconcile Net Income	0.64	0.69	0.66	0.78	1.06	1.07	1.27	1.06	1.15	1.20	1.14
Changes in Operating Assets and Liabilities, net	-12	-7.35	-15	-2.66	-3.24	0.61	14	0.78	2.36	13	6.85
Net Cash From Investing Activities	-1.92	-19	-101	98	-109	0.13	0.91	0.25	11	-19	13
Net Cash From Continuing Investing Activities	-1.92	-19	-101	98	-109	0.13	0.91	0.25	11	-19	13
Purchase of Property, Plant & Equipment	-1.92	-2.38	-2.21	-2.58	-1.73	-1.86	-2.41	-1.98	-1.22	-3.96	-2.07
Purchase of Investments	-	-	-99	-0.25	-112	-	-48	-	-76	-35	-39
Sale and/or Maturity of Investments	-	-	0.00	101	4.33	1.98	51	2.23	89	20	54
Net Cash From Financing Activities	0.20	9.51	114	-0.13	0.29	1.32	-15	-16	-5.22	-3.87	-6.39
Net Cash From Continuing Financing Activities	0.20	9.51	114	-0.13	0.29	1.32	-15	-16	-5.22	-3.87	-6.39
Repayment of Debt	-	-	-17	-	-	17	-2.97	-	-2.14	-0.03	0.08
Repurchase of Common Equity	-	-	0.00	-	-	-	-12	-16	-5.56	-	-6.28
Issuance of Common Equity	0.30	-	132	-	0.31	-0.00	0.25	-	0.34	0.00	0.30
Other Financing Activities, net	-0.10	-7.19	-1.30	-0.13	-0.02	1.32	-0.24	-0.01	-	-3.87	-0.49
Effect of Exchange Rate Changes	-	-	-	-	-0.13	-	0.09	-0.04	-0.00	-	0.13
Cash Interest Paid	-	0.12	0.21	0.06	0.09	0.10	0.09	0.09	0.13	0.09	0.06
Cash Income Taxes Paid	2.98	3.83	0.00	10	2.38	0.38	0.06	0.10	0.01	-0.01	0.41

This table presents Clearfield's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	9/30/2022	9/30/2023	9/30/2024
Total Assets	229	356	315
Total Current Assets	160	296	230
Cash & Equivalents	17	38	16
Short-Term Investments	5.80	130	115
Accounts Receivable	54	28	21
Inventories, net	82	98	67
Other Current Assets	1.76	1.70	11
Plant, Property, & Equipment, net	18	22	24
Total Noncurrent Assets	51	38	62
Long-Term Investments	23	6.34	25
Goodwill	6.40	6.53	6.63
Intangible Assets	6.38	6.09	6.34
Noncurrent Deferred & Refundable Income Taxes	1.41	3.04	6.14
Other Noncurrent Operating Assets	14	16	18
Total Liabilities & Shareholders' Equity	229	356	315
Total Liabilities	82	40	40
Total Current Liabilities	52	29	24
Accounts Payable	24	8.89	6.72
Accrued Expenses	6.18	2.40	4.38
Current Employee Benefit Liabilities	14	5.57	6.98
Other Current Liabilities	7.78	10	6.28
Total Noncurrent Liabilities	30	11	15
Long-Term Debt	19	0.00	2.23
Noncurrent Deferred & Payable Income Tax Liabilities	0.77	0.72	0.16
Other Noncurrent Operating Liabilities	10	11	13
Total Equity & Noncontrolling Interests	148	315	276
Total Preferred & Common Equity	148	315	276
Preferred Stock	0.00	0.00	0.00
Total Common Equity	148	315	276
Common Stock	55	188	160
Retained Earnings	95	127	115
Accumulated Other Comprehensive Income / (Loss)	-1.90	-0.54	1.08

This table presents Clearfield's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	6/30/2022	3/31/2023	6/30/2023	12/31/2023	3/31/2024	6/30/2024	12/31/2024
Total Assets	178	357	361	336	315	318	303
Total Current Assets	120	301	303	277	257	236	198
Cash & Equivalents	14	137	31	34	16	26	30
Short-Term Investments	3.89	20	131	128	127	98	83
Accounts Receivable	32	39	32	17	22	28	14
Inventories, net	69	101	105	95	84	75	59
Other Current Assets	1.05	3.66	4.08	1.81	8.64	9.88	12
Plant, Property, & Equipment, net	9.57	21	21	23	22	21	24
Total Noncurrent Assets	48	35	37	36	36	60	82
Long-Term Investments	25	8.53	6.56	6.51	6.52	24	42
Goodwill	4.71	6.59	6.58	6.62	6.57	6.55	6.49
Intangible Assets	4.69	6.46	6.34	5.98	6.22	6.40	6.10
Noncurrent Deferred & Refundable Income Taxes	0.65	0.96	1.00	2.75	2.84	5.51	6.62
Other Noncurrent Operating Assets	13	13	16	14	13	18	20
Total Liabilities & Shareholders' Equity	178	357	361	336	315	318	303
Total Liabilities	41	52	49	36	36	44	36
Total Current Liabilities	31	40	37	25	26	28	19
Accounts Payable	16	17	12	7.37	5.91	9.05	4.33
Accrued Expenses	2.76	5.05	3.34	2.75	2.74	3.03	2.56
Current Employee Benefit Liabilities	8.92	6.32	7.32	5.28	5.87	7.15	5.40
Other Current Liabilities	2.77	12	12	7.34	9.69	8.94	6.44
Total Noncurrent Liabilities	10	12	12	11	9.82	15	17
Long-Term Debt	-	2.18	0.00	-	-	2.14	2.07
Noncurrent Deferred & Payable Income Tax Liabilities	-	0.82	0.78	0.61	0.72	0.07	0.00
Other Noncurrent Operating Liabilities	10	8.94	12	9.97	9.10	13	15
Total Equity & Noncontrolling Interests	137	305	312	300	279	275	267
Total Preferred & Common Equity	137	305	312	300	279	275	267
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	137	305	312	300	279	275	267
Common Stock	60	186	188	177	163	159	154
Retained Earnings	78	119	125	122	116	116	113
Accumulated Other Comprehensive Income / (Loss)	-0.96	-0.23	-0.27	0.48	0.13	0.02	-0.02

This table displays calculated financial ratios and metrics derived from Clearfield's official financial filings.

Metric	2022	2023	2024
Period end date	9/30/2022	9/30/2023	9/30/2024
Growth Metrics	-	-	-
Revenue Growth	92.45%	-0.80%	-37.96%
EBITDA Growth	144.11%	-40.73%	-150.76%
EBIT Growth	152.90%	-41.57%	-162.28%
NOPAT Growth	147.59%	-40.93%	-155.76%
Net Income Growth	142.84%	-34.09%	-138.28%
EPS Growth	141.50%	-38.87%	-139.17%
Operating Cash Flow Growth	-79.29%	715.94%	20.62%
Free Cash Flow Firm Growth	-494.71%	126.01%	-44.87%
Invested Capital Growth	179.43%	17.98%	-14.23%
Revenue Q/Q Growth	80.78%	-30.26%	-1.72%
EBITDA Q/Q Growth	25.11%	-34.72%	-28.32%
EBIT Q/Q Growth	25.30%	-35.51%	-25.58%
NOPAT Q/Q Growth	24.99%	-35.05%	-25.58%
Net Income Q/Q Growth	24.04%	-30.53%	-39.45%
EPS Q/Q Growth	24.13%	-32.61%	-37.10%
Operating Cash Flow Q/Q Growth	134.72%	-22.49%	48.22%
Free Cash Flow Firm Q/Q Growth	-70.86%	207.49%	7.67%
Invested Capital Q/Q Growth	29.20%	-1.80%	-4.83%
Profitability Metrics	-	-	-
Gross Margin	41.70%	31.74%	17.33%
EBITDA Margin	24.81%	14.82%	-12.13%
Operating Margin	23.56%	13.88%	-13.93%
EBIT Margin	23.56%	13.88%	-13.93%
Profit (Net Income) Margin	18.22%	12.11%	-7.47%
Tax Burden Percent	77.33%	78.18%	76.61%
Interest Burden Percent	100.03%	111.60%	70.00%
Effective Tax Rate	22.67%	21.82%	0.00%
Return on Invested Capital (ROIC)	60.05%	22.10%	-12.25%
ROIC Less NNEP Spread (ROIC-NNEP)	60.02%	18.70%	-14.59%
Return on Net Nonoperating Assets (RNNOA)	-20.78%	-8.03%	8.04%
Return on Equity (ROE)	39.27%	14.06%	-4.21%
Cash Return on Invested Capital (CROIC)	-34.53%	5.59%	3.07%
Operating Return on Assets (OROA)	35.95%	12.76%	-6.92%
Return on Assets (ROA)	27.81%	11.13%	-3.71%
Return on Common Equity (ROCE)	39.27%	14.06%	-4.21%
Return on Equity Simple (ROE_SIMPLE)	33.45%	10.32%	-4.52%
Net Operating Profit after Tax (NOPAT)	49	29	-16
NOPAT Margin	18.22%	10.85%	-9.75%
Net Nonoperating Expense Percent (NNEP)	0.03%	3.40%	2.34%
Cost of Revenue to Revenue	58.30%	68.26%	82.67%
SG&A Expenses to Revenue	18.14%	17.86%	31.26%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	18.14%	17.86%	31.26%
Earnings before Interest and Taxes (EBIT)	64	37	-23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	67	40	-20
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	9.77	1.39	2.01
Price to Tangible Book Value (P/TBV)	10.69	1.45	2.11
Price to Revenue (P/Rev)	5.32	1.63	3.33
Price to Earnings (P/E)	29.21	13.44	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	3.42%	7.44%	0.00%
Enterprise Value to Invested Capital (EV/IC)	11.69	1.86	3.28
Enterprise Value to Revenue (EV/Rev)	5.22	0.99	2.41
Enterprise Value to EBITDA (EV/EBITDA)	21.06	6.65	0.00
Enterprise Value to EBIT (EV/EBIT)	22.18	7.11	0.00
Enterprise Value to NOPAT (EV/NOPAT)	28.68	9.09	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	626.73	14.39	18.06
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	35.91	98.64
Leverage & Solvency	-	-	-
Debt to Equity	0.13	0.01	0.01
Long-Term Debt to Equity	0.13	0.00	0.01
Financial Leverage	-0.35	-0.43	-0.55
Leverage Ratio	1.41	1.26	1.14
Compound Leverage Factor	1.41	1.41	0.79
Debt to Total Capital	11.23%	0.67%	0.80%
Short-Term Debt to Total Capital	0.00%	0.67%	0.00%
Long-Term Debt to Total Capital	11.23%	0.00%	0.80%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	88.77%	99.33%	99.20%
Debt to EBITDA	0.28	0.05	-0.11
Net Debt to EBITDA	-0.39	-4.33	7.58
Long-Term Debt to EBITDA	0.28	0.00	-0.11
Debt to NOPAT	0.38	0.07	-0.14
Net Debt to NOPAT	-0.54	-5.91	9.43
Long-Term Debt to NOPAT	0.38	0.00	-0.14
Altman Z-Score	13.86	9.01	10.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	3.10	10.21	9.43
Quick Ratio	1.47	6.78	6.25
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-28	7.38	4.07
Operating Cash Flow to CapEx	24.68%	219.75%	232.29%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	1.53	0.92	0.50
Accounts Receivable Turnover	7.41	6.55	6.71
Inventory Turnover	2.88	2.04	1.67
Fixed Asset Turnover	23.32	13.52	7.33
Accounts Payable Turnover	9.48	11.11	17.66
Days Sales Outstanding (DSO)	49.28	55.76	54.41
Days Inventory Outstanding (DIO)	126.80	179.34	218.26
Days Payable Outstanding (DPO)	38.52	32.84	20.67
Cash Conversion Cycle (CCC)	137.56	202.25	252.00
Capital & Investment Metrics	-	-	-
Invested Capital	121	143	122
Invested Capital Turnover	3.30	2.04	1.26
Increase / (Decrease) in Invested Capital	78	22	-20
Enterprise Value (EV)	1,415	265	401
Market Capitalization	1,442	437	555
Book Value per Share	$10.71	$20.65	$19.37
Tangible Book Value per Share	$9.78	$19.82	$18.46
Total Capital	166	317	278
Total Debt	19	2.11	2.23
Total Long-Term Debt	19	0.00	2.23
Net Debt	-27	-172	-153
Capital Expenditures (CapEx)	9.15	8.38	9.57
Debt-free, Cash-free Net Working Capital (DFCFNWC)	86	101	74
Debt-free Net Working Capital (DFNWC)	108	269	205
Net Working Capital (NWC)	108	267	205
Net Nonoperating Expense (NNE)	-0.01	-3.38	-3.80
Net Nonoperating Obligations (NNO)	-27	-172	-153
Total Depreciation and Amortization (D&A)	3.38	2.54	3.01
Debt-free, Cash-free Net Working Capital to Revenue	31.74%	37.68%	44.54%
Debt-free Net Working Capital to Revenue	40.03%	100.24%	123.12%
Net Working Capital to Revenue	40.03%	99.45%	123.12%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$3.58	$2.17	($0.85)
Adjusted Weighted Average Basic Shares Outstanding	13.77M	14.98M	14.58M
Adjusted Diluted Earnings per Share	$3.55	$2.17	($0.85)
Adjusted Weighted Average Diluted Shares Outstanding	13.91M	15.01M	14.58M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	13.82M	15.25M	14.29M
Normalized Net Operating Profit after Tax (NOPAT)	49	29	-16
Normalized NOPAT Margin	18.22%	10.85%	-9.75%
Pre Tax Income Margin	23.57%	15.49%	-9.75%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	-268.00%

This table displays calculated financial ratios and metrics derived from Clearfield's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-100.00%	267.58%	68.15%	34.24%	0.00%	-70.12%	-60.17%	-48.60%	-20.38%	-5.86%	3.64%
EBITDA Growth	110.17%	135.93%	39.10%	-0.32%	-65.99%	-90.29%	-140.32%	-170.62%	-125.41%	-195.96%	62.14%
EBIT Growth	115.35%	137.55%	37.10%	1.04%	-66.09%	-92.28%	-145.62%	-180.80%	-141.00%	-275.48%	51.29%
NOPAT Growth	111.74%	134.61%	38.01%	2.45%	-67.30%	-91.75%	-140.21%	-172.79%	-138.83%	-248.72%	51.29%
Net Income Growth	109.00%	128.82%	37.21%	12.21%	-59.06%	-84.13%	-136.96%	-157.03%	-108.57%	-130.68%	63.82%
EPS Growth	109.09%	130.19%	33.33%	1.52%	-64.13%	-86.07%	-135.00%	-159.70%	-112.12%	-135.29%	62.86%
Operating Cash Flow Growth	40.55%	314.47%	3,344.12%	180.35%	67.59%	-57.19%	879.15%	-135.74%	15.78%	178.35%	-33.80%
Free Cash Flow Firm Growth	-10,759.49%	-1,018.58%	-402.53%	328.86%	-9.71%	66.38%	104.62%	-254.71%	131.75%	189.51%	372.02%
Invested Capital Growth	149.17%	179.43%	152.53%	0.00%	55.23%	17.98%	-6.35%	0.00%	-11.50%	-14.23%	-13.83%
Revenue Q/Q Growth	-100.00%	0.00%	-48.31%	-16.44%	-14.66%	-18.93%	-31.11%	7.83%	32.19%	-4.14%	-24.15%
EBITDA Q/Q Growth	37.76%	34.69%	-18.91%	-33.76%	-53.00%	-61.56%	-436.89%	-16.69%	83.09%	-45.18%	-32.91%
EBIT Q/Q Growth	39.02%	34.16%	-19.60%	-32.62%	-53.34%	-69.48%	-575.36%	-19.35%	76.33%	-30.66%	-31.96%
NOPAT Q/Q Growth	39.03%	35.29%	-17.39%	-34.07%	-55.62%	-65.89%	-502.86%	-19.35%	76.33%	-30.66%	-31.96%
Net Income Q/Q Growth	37.99%	33.32%	-16.11%	-27.30%	-49.65%	-48.33%	-295.40%	-12.21%	92.44%	-85.01%	-130.47%
EPS Q/Q Growth	39.39%	32.61%	-18.03%	-33.00%	-50.75%	-48.48%	-305.88%	-14.29%	90.00%	-50.00%	-116.67%
Operating Cash Flow Q/Q Growth	117.72%	479.38%	-89.28%	719.40%	-63.04%	47.99%	118.49%	-141.27%	219.72%	255.81%	-48.03%
Free Cash Flow Firm Q/Q Growth	-10.69%	-39.54%	-18.21%	225.34%	-153.06%	57.23%	116.25%	-4,296.33%	110.89%	20.56%	-14.32%
Invested Capital Q/Q Growth	16.65%	29.20%	17.30%	-100.00%	0.00%	-1.80%	-6.90%	-0.78%	-2.44%	-4.83%	-6.46%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	22.55%	35.66%	32.81%	31.12%	24.14%	13.72%	7.67%	21.91%	22.81%	23.06%
EBITDA Margin	0.00%	14.11%	22.14%	17.55%	9.67%	4.58%	-22.41%	-24.11%	-3.08%	-4.67%	-8.19%
Operating Margin	0.00%	13.38%	20.82%	16.79%	9.18%	3.46%	-23.84%	-26.39%	-4.73%	-6.44%	-11.21%
EBIT Margin	0.00%	13.38%	20.82%	16.79%	9.18%	3.46%	-23.84%	-26.39%	-4.73%	-6.44%	-11.21%
Profit (Net Income) Margin	0.00%	10.22%	16.59%	14.43%	8.51%	5.43%	-15.39%	-16.01%	-0.92%	-1.77%	-5.37%
Tax Burden Percent	76.64%	77.29%	79.42%	77.70%	73.91%	82.60%	84.71%	73.94%	61.74%	62.70%	81.73%
Interest Burden Percent	100.26%	98.80%	100.34%	110.64%	125.51%	190.10%	76.19%	82.07%	31.40%	43.78%	58.65%
Effective Tax Rate	23.36%	22.71%	20.59%	22.30%	26.09%	17.40%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	34.09%	50.99%	0.00%	21.86%	5.81%	-26.35%	-51.00%	-4.09%	-5.67%	-10.65%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	34.57%	50.95%	0.00%	20.85%	4.53%	-26.62%	-52.23%	-4.84%	-6.45%	-11.19%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-11.97%	-26.90%	0.00%	-9.74%	-1.95%	14.53%	27.55%	2.58%	3.56%	6.31%
Return on Equity (ROE)	0.00%	22.12%	24.10%	0.00%	12.12%	3.87%	-11.82%	-23.45%	-1.52%	-2.11%	-4.33%
Cash Return on Invested Capital (CROIC)	-25.30%	-34.53%	-32.79%	0.00%	-5.74%	5.59%	12.66%	-211.21%	2.76%	3.07%	4.09%
Operating Return on Assets (OROA)	0.00%	20.42%	25.70%	0.00%	13.12%	3.18%	-14.93%	-15.24%	-2.36%	-3.20%	-5.89%
Return on Assets (ROA)	0.00%	15.59%	20.48%	0.00%	12.17%	4.99%	-9.64%	-9.25%	-0.46%	-0.88%	-2.82%
Return on Common Equity (ROCE)	0.00%	22.12%	24.10%	0.00%	12.12%	3.87%	-11.82%	-23.45%	-1.52%	-2.11%	-4.33%
Return on Equity Simple (ROE_SIMPLE)	29.10%	0.00%	17.43%	0.00%	15.01%	0.00%	4.34%	-1.17%	-3.25%	0.00%	-3.40%
Net Operating Profit after Tax (NOPAT)	13	17	14	9.37	4.16	1.42	-5.71	-6.82	-1.61	-2.11	-2.78
NOPAT Margin	0.00%	10.34%	16.53%	13.04%	6.78%	2.85%	-16.69%	-18.47%	-3.31%	-4.51%	-7.85%
Net Nonoperating Expense Percent (NNEP)	0.06%	-0.47%	0.04%	0.00%	1.01%	1.29%	0.27%	1.23%	0.75%	0.79%	0.55%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-1.89%	-	-	-	-1.03%
Cost of Revenue to Revenue	0.00%	59.82%	64.34%	67.19%	68.88%	75.86%	86.28%	92.33%	78.09%	77.19%	76.94%
SG&A Expenses to Revenue	0.00%	9.17%	14.85%	16.03%	21.95%	20.68%	37.57%	34.06%	26.64%	29.25%	34.27%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	9.17%	14.85%	16.03%	21.95%	20.68%	37.57%	34.06%	26.64%	29.25%	34.27%
Earnings before Interest and Taxes (EBIT)	17	22	18	12	5.63	1.72	-8.16	-9.74	-2.31	-3.01	-3.98
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	17	23	19	13	5.92	2.28	-7.67	-8.90	-1.51	-2.19	-2.90
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.24	9.77	4.26	0.00	2.32	1.39	1.48	1.62	2.00	2.01	1.66
Price to Tangible Book Value (P/TBV)	6.70	10.69	4.45	0.00	2.42	1.45	1.54	1.70	2.10	2.11	1.74
Price to Revenue (P/Rev)	5.69	5.32	4.26	2.19	1.87	1.63	2.05	2.49	3.24	3.33	2.64
Price to Earnings (P/E)	81.34	29.21	24.44	13.04	9.49	13.44	34.11	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.23%	3.42%	4.09%	7.67%	10.54%	7.44%	2.93%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	8.65	11.69	8.01	0.00	3.82	1.86	2.08	2.32	3.13	3.28	2.53
Enterprise Value to Revenue (EV/Rev)	5.41	5.22	3.72	0.00	1.44	0.99	1.28	1.68	2.38	2.41	1.73
Enterprise Value to EBITDA (EV/EBITDA)	15.08	21.06	15.68	0.00	9.11	6.65	21.07	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	15.90	22.18	16.57	0.00	9.61	7.11	24.63	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	20.52	28.68	21.36	0.00	12.38	9.09	33.02	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	626.73	532.02	0.00	23.38	14.39	9.84	21.17	26.88	18.06	15.62
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	35.91	15.90	0.00	106.62	98.64	57.26
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.13	0.01	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Long-Term Debt to Equity	0.00	0.13	0.01	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01
Financial Leverage	-0.44	-0.35	-0.53	0.00	-0.47	-0.43	-0.55	-0.53	-0.53	-0.55	-0.56
Leverage Ratio	1.25	1.41	1.18	0.00	1.20	1.26	1.14	1.13	1.16	1.14	1.13
Compound Leverage Factor	1.26	1.40	1.18	0.00	1.51	2.40	0.87	0.93	0.36	0.50	0.66
Debt to Total Capital	0.00%	11.23%	0.71%	0.00%	0.69%	0.67%	0.73%	0.77%	0.77%	0.80%	0.77%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.69%	0.67%	0.73%	0.77%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	11.23%	0.71%	0.00%	0.00%	0.00%	0.00%	0.00%	0.77%	0.80%	0.77%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	88.77%	99.29%	0.00%	99.31%	99.33%	99.27%	99.23%	99.23%	99.20%	99.23%
Debt to EBITDA	0.00	0.28	0.03	0.00	0.04	0.05	0.17	-0.26	-0.14	-0.11	-0.13
Net Debt to EBITDA	0.00	-0.39	-2.25	0.00	-2.73	-4.33	-12.73	17.69	9.26	7.58	9.89
Long-Term Debt to EBITDA	0.00	0.28	0.03	0.00	0.00	0.00	0.00	0.00	-0.14	-0.11	-0.13
Debt to NOPAT	0.00	0.38	0.04	0.00	0.05	0.07	0.26	-0.29	-0.17	-0.14	-0.16
Net Debt to NOPAT	0.00	-0.54	-3.07	0.00	-3.71	-5.91	-19.94	19.92	11.27	9.43	11.47
Long-Term Debt to NOPAT	0.00	0.38	0.04	0.00	0.00	0.00	0.00	0.00	-0.17	-0.14	-0.16
Altman Z-Score	14.80	13.26	17.38	0.00	11.28	8.68	9.47	9.39	9.37	10.21	9.17
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.91	3.10	7.51	0.00	8.21	10.21	11.09	9.76	8.38	9.43	10.57
Quick Ratio	1.62	1.47	4.91	0.00	5.26	6.78	7.22	6.25	5.38	6.25	6.79
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-43	-61	-72	90	-48	-20	3.31	-139	15	18	16
Operating Cash Flow to CapEx	103.69%	484.35%	49.84%	349.77%	192.84%	266.47%	447.76%	-163.38%	317.23%	347.54%	345.58%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.03	1.53	1.23	0.00	1.43	0.92	0.63	0.58	0.50	0.50	0.53
Accounts Receivable Turnover	6.27	7.41	10.97	0.00	12.13	6.55	7.65	8.32	5.69	6.71	10.69
Inventory Turnover	1.86	2.88	2.56	0.00	2.81	2.04	1.61	1.71	1.55	1.67	1.76
Fixed Asset Turnover	20.68	23.32	22.10	0.00	24.95	13.52	9.87	8.12	7.93	7.33	7.21
Accounts Payable Turnover	7.34	9.48	12.75	0.00	17.59	11.11	13.12	24.27	13.48	17.66	23.19
Days Sales Outstanding (DSO)	58.19	49.28	33.26	0.00	30.09	55.76	47.72	43.89	64.10	54.41	34.15
Days Inventory Outstanding (DIO)	196.29	126.80	142.39	0.00	129.75	179.34	226.22	213.60	235.48	218.26	207.08
Days Payable Outstanding (DPO)	49.75	38.52	28.64	0.00	20.75	32.84	27.83	15.04	27.09	20.67	15.74
Cash Conversion Cycle (CCC)	204.73	137.56	147.01	0.00	139.10	202.25	246.11	242.45	272.50	252.00	225.49
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	94	121	142	0.00	145	143	133	132	129	122	115
Invested Capital Turnover	2.28	3.30	3.08	0.00	3.22	2.04	1.58	2.76	1.24	1.26	1.36
Increase / (Decrease) in Invested Capital	56	78	86	-80	52	22	-9.02	132	-17	-20	-18
Enterprise Value (EV)	810	1,415	1,137	0.00	556	265	277	306	403	401	290
Market Capitalization	853	1,442	1,301	709	722	437	444	454	549	555	443
Book Value per Share	$9.93	$10.71	$22.10	$0.00	$20.45	$20.65	$19.73	$18.99	$19.29	$19.37	$18.72
Tangible Book Value per Share	$9.25	$9.78	$21.16	$0.00	$19.60	$19.82	$18.90	$18.12	$18.38	$18.46	$17.84
Total Capital	137	166	308	0.00	314	317	302	281	277	278	270
Total Debt	0.00	19	2.18	0.00	2.17	2.11	2.21	2.16	2.14	2.23	2.07
Total Long-Term Debt	0.00	19	2.18	0.00	0.00	0.00	0.00	0.00	2.14	2.23	2.07
Net Debt	-43	-27	-163	0.00	-166	-172	-167	-147	-146	-153	-153
Capital Expenditures (CapEx)	1.92	2.38	2.21	2.58	1.73	1.86	2.41	1.98	1.22	3.96	2.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)	71	86	104	0.00	106	101	91	90	84	74	66
Debt-free Net Working Capital (DFNWC)	89	108	261	0.00	268	269	254	233	208	205	179
Net Working Capital (NWC)	89	108	261	0.00	266	267	252	231	208	205	179
Net Nonoperating Expense (NNE)	-0.03	0.21	-0.05	-1.00	-1.06	-1.28	-0.45	-0.91	-1.17	-1.28	-0.88
Net Nonoperating Obligations (NNO)	-43	-27	-163	0.00	-166	-172	-167	-147	-146	-153	-153
Total Depreciation and Amortization (D&A)	0.83	1.21	1.14	0.55	0.30	0.56	0.49	0.84	0.80	0.83	1.07
Debt-free, Cash-free Net Working Capital to Revenue	47.58%	31.74%	33.96%	0.00%	27.59%	37.68%	41.95%	49.59%	49.65%	44.54%	39.40%
Debt-free Net Working Capital to Revenue	59.65%	40.03%	85.34%	0.00%	69.66%	100.24%	116.99%	128.06%	122.65%	123.12%	106.69%
Net Working Capital to Revenue	59.65%	40.03%	85.34%	0.00%	69.09%	99.45%	115.97%	126.88%	122.65%	123.12%	106.69%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.93	$1.22	$0.00	$0.00	$0.33	$0.16	($0.35)	($0.40)	($0.04)	($0.06)	($0.13)
Adjusted Weighted Average Basic Shares Outstanding	13.77M	13.77M	0.00	0.00	15.25M	14.98M	15.21M	14.63M	14.25M	14.58M	14.21M
Adjusted Diluted Earnings per Share	$0.92	$1.22	$0.00	$0.00	$0.33	$0.17	($0.35)	($0.40)	($0.04)	($0.06)	($0.13)
Adjusted Weighted Average Diluted Shares Outstanding	13.90M	13.91M	0.00	0.00	15.25M	15.01M	15.21M	14.63M	14.25M	14.58M	14.21M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	13.78M	13.82M	0.00	0.00	15.26M	15.25M	14.71M	14.23M	14.24M	14.29M	14.13M
Normalized Net Operating Profit after Tax (NOPAT)	13	17	14	9.37	4.16	1.42	-5.71	-6.82	-1.61	-2.11	-2.78
Normalized NOPAT Margin	0.00%	10.34%	16.53%	13.04%	6.78%	2.85%	-16.69%	-18.47%	-3.31%	-4.51%	-7.85%
Pre Tax Income Margin	0.00%	13.22%	20.89%	18.57%	11.52%	6.57%	-18.17%	-21.66%	-1.48%	-2.82%	-6.57%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	93.65%	0.00%	0.00%	-268.00%	-302.11%

Key Financial Trends

Clearfield, Inc. (NASDAQ: CLFD) has reported its latest quarterly financial results for Q1 2025, providing insight into its recent performance and financial health. We analyzed key data points spanning income statements, cash flow statements, and balance sheets over the last four years to identify trends and developments.

Positive factors observed:

Clearfield maintains strong liquidity with a sizeable cash and short-term investments balance of approximately $112 million in Q1 2025, providing financial flexibility.
Net cash from operating activities remains positive in Q1 2025, generating $7.15 million despite the net loss on the income statement, indicating solid cash flow management.
Consistent investment in property, plant, and equipment (~$2 million quarterly), showing commitment to maintaining or growing operational capacity.
The company has low long-term debt relative to total assets, with about $2 million in long-term debt against total assets of $303 million as of Q1 2025, indicating a strong balance sheet.
Over the past year, Clearfield has been able to continue generating substantial total revenues, generally ranging from about $34 million to $49 million quarterly, reflecting sustained demand for its products.
Depreciation and non-cash adjustments help to reconcile net income to cash flow, providing positive adjustments to operating cash flows.
Weighted average shares outstanding have remained relatively stable around 14-15 million shares, minimizing dilution concerns in the recent periods analyzed.

Neutral observations:

Net losses reported in recent quarters (including a $1.9 million loss in Q1 2025) signal ongoing challenges in achieving profitability during these periods, though this is partly offset by other income.
Clearfield’s operating expenses, particularly selling, general & admin expenses, are higher than gross profit in recent quarters, contributing to operating losses but they have been fairly consistent around $12-13 million.
Interest and investment income provide some positive offset to operating losses but have not been sufficient to bring pre-tax income into positive territory in recent quarters.
Inventory levels remain high at approximately $59 million as of Q1 2025, which might suggest buildup or slower movement but could also reflect strategic stocking depending on demand cycles.
Accounts receivable decreased from prior quarters (Q1 2025 at $14 million, down from higher levels in prior quarters), which may indicate improving collections or sales mix impacts.

Negative trends and risks:

The company experienced a decline in total revenue from Q3 2024 ($48.8 million) down to $35.5 million in Q1 2025, indicating softening sales that may pressure margins and earnings.
Net income has been negative for several recent quarters, including Q1 2024 to Q1 2025, reflecting operational profitability pressures.
Significant purchases of investments and large sales/maturities of investments in recent quarters cause fluctuations in investing cash flows, which might add volatility to reported cash positions.
There has been consistent share repurchase activity (millions of dollars spent over quarters) which reduces cash and equity but is likely aimed at supporting share price — this warrants careful monitoring of capital allocation efficiency.
The company's gross profit margins have compressed recently as cost of revenue remains a high percentage of total revenue, impacting overall profitability.

Summary:

Clearfield shows solid liquidity and positive operating cash flow despite recent net losses. The company continues to invest in its operations and manage its balance sheet conservatively with low debt. However, revenue softness and profitability challenges persist, highlighted by operating losses and consistent net losses over recent quarters. Investors should watch for signs of revenue stabilization and improved profitability in coming quarters alongside effective capital deployment strategies.

08/24/25 04:26 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Clearfield's Financials

When does Clearfield's financial year end?

According to the most recent income statement we have on file, Clearfield's fiscal year ends in September. Their fiscal year 2024 ended on September 30, 2024.

How has Clearfield's net income changed over the last 2 years?

Clearfield's net income appears to be on a downward trend, with a most recent value of -$12.45 million in 2024, falling from $49.36 million in 2022. The previous period was $32.53 million in 2023. View Clearfield's forecast to see where analysts expect Clearfield to go next.

What is Clearfield's operating income?

Clearfield's total operating income in 2024 was -$23.22 million, based on the following breakdown:

Total Gross Profit: $28.89 million
Total Operating Expenses: $52.11 million

How has Clearfield's revenue changed over the last 2 years?

Over the last 2 years, Clearfield's total revenue changed from $270.88 million in 2022 to $166.71 million in 2024, a change of -38.5%.

How much debt does Clearfield have?

Clearfield's total liabilities were at $39.51 million at the end of 2024, a 2.1% decrease from 2023, and a 51.5% decrease since 2022.

How much cash does Clearfield have?

In the past 2 years, Clearfield's cash and equivalents has ranged from $16.17 million in 2024 to $37.83 million in 2023, and is currently $16.17 million as of their latest financial filing in 2024.

How has Clearfield's book value per share changed over the last 2 years?

Over the last 2 years, Clearfield's book value per share changed from 10.71 in 2022 to 19.37 in 2024, a change of 80.8%.

Related Companies

This page (NASDAQ:CLFD) was last updated on 8/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Clearfield (CLFD) Financials

Key Financial Trends

Frequently Asked Questions About Clearfield's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Clearfield (CLFD) Financials

Annual Income Statements for Clearfield

Quarterly Income Statements for Clearfield

Annual Cash Flow Statements for Clearfield

Quarterly Cash Flow Statements for Clearfield

Annual Balance Sheets for Clearfield

Quarterly Balance Sheets for Clearfield

Annual Metrics And Ratios for Clearfield

Quarterly Metrics And Ratios for Clearfield

Key Financial Trends

Frequently Asked Questions About Clearfield's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools